FernandoMartinezMD

PubMed

• 278 citations
  Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials.
  Joyce S. Lee, Harold R. Collard, Kevin J. Anstrom, Fernando J. Martinez, Imre Noth
  The Lancet. Respiratory Medicine. 2013-07-01
• 1279 citations
  An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline
  Ganesh Raghu, Bram Rochwerg, Yuan Zhang, Carlos A. Cuello Garcia, Arata Azuma
  American Journal of Respiratory and Critical Care Medicine. 2015-07-15
• 4037 citations
  An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-Based Guidelines for Diagnosis and Management
  Ganesh Raghu, Harold R. Collard, Jim J. Egan, Fernando J. Martinez, Juergen Behr
  American Journal of Respiratory and Critical Care Medicine. 2011-03-15

Journal Articles

• Idiopathic interstitial pneumonia or idiopathic interstitial pneumonitis: what�s in a name?  
  Wells AU, Brown KK, Flaherty KR, Kolb M, Thannickal VJ; IPF Consensus Working Group; IPF Consensus Working Group, Eur Respir J, 1/1/2019
• Mortality and Exacerbations by Global Initiative for Chronic Obstructive Lung Disease Groups ABCD: 2011 Versus 2017 in the COPDGene Cohort  
  Criner RN, Labaki WW, Regan EA, Bon JM, Soler X, Bhatt SP, Murray S, Hokanson JE, Silverman EK, Crapo JD, Curtis JL, Martinez FJ, Make BJ, Han MK, Martinez CH; COPDGen..., Chronic Obstr Pulm Dis, 1/1/2019
• Voxel-wise longitudinal parametric response mapping analysis of chest computed tomography in smokers  
  Labaki WW, Gu T, Murray S, Hatt CR, Galban CJ, Ross BD, Martinez CH, Curtis JL, Hoffman EA, Pompe E, Lynch DA, Kazerooni EA, Martinez FJ, Han MK, Acad Radiol, 1/1/2019
• Why an aging lung develops IPF and not COPD?  
  Selman M, Martinez FJ, Pardo A, Am J Respir Crit Care Med, 1/1/2019
• Computed tomographic biomarkers in idiopathic pulmonary fibrosis: the future of quantitative analysis  
  Wu X, Kim GH, Salisbury ML, Barber D, Bartholmai BJ, Brown KK, Conoscenti CS, De Backer J, Flaherty KR, Gruden JF, Hoffman EA, Humphries SM, Jacob J, Maher TM, Raghu G..., Am J Respir Crit Care Med, 1/1/2019
• Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts  
  Volkmann ER, Tashkin DP, Sim M, Li N, Goldmuntz E, Keyes-Elstein L, Pinckney A, Furst DE, Clements PJ, Khanna D, Steen V, Schraufnagel DE, Arami S, Hsu V, Roth MD, Ela..., Ann Rheum Dis, 1/1/2019
• Clinical approach to the therapy of Asthma-COPD Overlap  
  Maselli DJ, Hardin M, Christenson SA, Hanania NA, Hersh CP, Adams SG, Anzueto A, Peters JI, Han MK, Martinez FJ, Chest, 1/1/2019
• Aspirin use and respiratory morbidity in COPD: A propensity score-matched analysis in subpopulations and intermediate outcome measures in COPD Study  
  Fawzy A, Putcha N, Aaron CP, Bowler RP, Comellas AP, Cooper CB, Dransfield MT, Han MK, Hoffman EA, Kanner RE, Krishnan JA, Labaki WW, Paine R 3rd, Paulin LM, Peters SP..., Chest, 1/26/2018
• Closing the Evidence Gap in Interstitial Lung Disease: The Promise of Real World Data  
  Farrand E, Anstrom KJ, Bernard G, Butte AJ, Iribarren C, Ley B, Martinez F, Collard HR, Am J Respir Crit Care Med, 1/19/2018
• Hypersensitivity pneumonitis: radiologic phenotypes are associated with distinct survival time and pulmonary function trajectory  
  Salisbury ML, Gu T, Murray S, Gross BH, Chughtai A, Sayyouh M, Kazerooni EA, Myers JL, Lagstein A, Konopka KE, Belloli EA, Sheth JS, White ES, Holtze C, Martinez FJ, F..., Chest, 1/19/2018
• Genome-wide association study of lung function and clinical implication in heavy smokers  
  Li X, Ortega VE, Ampleford EJ, Graham Barr R, Christenson SA, Cooper CB, Couper D, Dransfield MT, Han MLK, Hansel NN, Hoffman EA, Kanner RE, Kleerup EC, Martinez FJ, P..., BMC Med Genet, 1/1/2018
• Precision medicine in COPD: where are we and where do we need to go?  
  Sidhaye VK, Nishida K, Martinez FJ, Eur Respir Rev, 1/1/2018
• Mitochondrial Dysfunction as a Pathogenic Mediator of Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis  
  Ryter SW, Rosas IO, Owen CA, Martinez FJ, Choi ME, Lee CG, Elias JA, Choi AMK, Ann Am Thorac Soc, 1/1/2018
• Centrilobular emphysema and coronary artery calcification: mediation analysis in the SPIROMICS cohort  
  Bhatt SP, Nath HP, Kim YI, Ramachandran R, Watts JR, Terry NLJ, Sonavane S, Deshmane SP, Woodruff PG, Oelsner EC, Bodduluri S, Han MK, Labaki WW, Michael Wells J, Mart..., Respir Res, 1/1/2018
• Anemia and Adverse Outcomes in a Chronic Obstructive Pulmonary Disease Population with a High Burden of Comorbidities An Analysis from SPIROMICS  
  Putcha N, Fawzy A, Paul GG, Lambert AA, Psoter KJ, Sidhaye VK, Woo J, Wells JM, Labaki WW, Doerschuk CM, Kanner RE, Han MK, Martinez C, Paulin LM, Martinez FJ, Wise RA..., Ann Am Thorac Soc, 1/1/2018
• Elevated circulating MMP-9 is linked to increased COPD exacerbation risk in SPIROMICS and COPDGene  
  Wells JM, Parker MM, Oster RA, Bowler RP, Dransfield MT, Bhatt SP, Cho MH, Kim V, Curtis JL, Martinez FJ, Paine R 3rd, O'Neal W, Labaki WW, Kaner RJ, Barjaktarevic I, ..., JCI Insight, 1/1/2018
• Diagnosis of Idiopathic Pulmonary Fibrosis An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline  
  Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, Behr J, Cottin V, Danoff SK, Morell F, Flaherty KR, Wells A, Martinez FJ, Azuma A, Bice TJ, Bouro..., Am J Respir Crit Care Med, 1/1/2018
• Cardiac troponin I and Cardiovascular Risk in Patients with Chronic Obstructive Pulmonary Disease  
  Adamson PD, Anderson JA, Brook RD, Calverley PMA, Celli BR, Cowans NJ, Crim C, Dixon IJ, Martinez FJ, Newby DE, Vestbo J, Yates JC, Mills NL, J Am Coll Cardiol, 1/1/2018
• Imaging-based clusters in current smokers of the COPD cohort associated with clinical characteristics: the SubPopulations and Intermediate Outcome Measures in COPD Stu...  
  Haghighi B, Choi S, Choi J, Hoffman EA, Comellas AP, Newell JD Jr, Graham Barr R, Bleecker E, Cooper CB, Couper D, Han ML, Hansel NN, Kanner RE, Kazerooni EA, Kleerup ..., Respir Res, 1/1/2018
• Association between emphysema and COPD outcomes in COPDGene and SPIROMICS  
  Han MK, Tayob N, Murray S, Woodruff PG, Curtis JL, Kim V, Criner G, Galban CJ, Ross BD, Hoffman EA, Lynch DA, Kazerooni E, Martinez FJ; COPDGene and SPIROMICS Investig..., Am J Respir Crit Care Med, 1/1/2018
• Determinants of response to roflumilast in severe COPD: pooled analysis of two randomized trials  
  Martinez FJ, Rabe KF, Calverley PMA, Fabbri LM, Sethi S, Pizzichini E, McIvor A, Anzueto A, Alagappan VKT, Siddiqui S, Reisner C, Zetterstrand S, Roman J, Purkayastha ..., Am J Respir Crit Care Med, 1/1/2018
• Relationship of absolute telomere length with quality of life, exacerbations, and mortality in COPD  
  Jin M, Lee EC, Ra SW, Fishbane N, Tam S, Criner GJ, Woodruff PG, Lazarus SC, Albert R, Connett JE, Han MK, Martinez FJ, Aaron SD, Reed RM, Man SFP, Leung JM, Sin DD, Chest, 1/1/2018
• Triple therapy with budesonide/ glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disea...  
  Ferguson GT, Rabe KF, Martinez FJ, Fabbri LM, Wang C, Ichinose M, Bourne E, Ballal S, Darken P, DeAngelis K, Aurivillius M, Dorinsky P, Reisner C, Lancet Respir Med, 1/1/2018
• Laparoscopic anti-reflux surgery for the treatment of idiopathic pulmonary fibrosis (WRAP-IPF): a multicenter, randomized, controlled phase 2 trial  
  Raghu G, Pellegrini CA, Yow E, Flaherty KR, Meyer K, Noth I, Scholand MB, Cello J, Ho LA, Pipavath S, Lee JS, Lin J, Maloney J, Martinez FJ, Morrow E, Patti MG, Rogers..., Lancet Respir Med, 1/1/2018
• Nintedanib plus sildenafil in patients with Idiopathic Pulmonary Fibrosis  
  Kolb M, Raghu G, Wells AU, Behr J, Richeldi L, Schinzel B, Quaresma M, Stowasser S, Martinez FJ; INSTAGE Investigators, N Engl J Med, 1/1/2018
• Join now to see all

Books/Book Chapters

• Interstitial Lung Disease 
  Chapter: Non-specific interstitial pneumonia. 
  Page 945 - 960Martinez FJ, Flaherty KREditors: Schwartz M, King Jr. TE.People's Medical Publishing House, Shelton, CTEdition 5th,2010
• Lung Biology in Health and Disease Vol. 228. 
  Chapter: Chronic Obstructive Pulmonary Disease Exacerbations. 
  Wedzicha JA, Martinez FJInforma Healthcare, New York, NY2009
• Chronic Obstructive Pulmonary Disease Exacerbations. Lung biology in health and disease, vol 228 (Lenfant C, series editor). 
  Chapter: Design of trials for COPD exacerbations. 
  Page 387 - 405Martinez FJ, Han MK, Curtis JLEditors: Wedzicha JA, Martinez FJ.Informa Healthcare, New York, NY2009
• Therapeutic strategies in acute exacerbations in COPD. 
  Chapter: Prevention of acute exacerbations of COPD. 
  Page 179 - 205Martinez FJ, Curtis JLEditors: Cazzola M, Sethi S, Blasi F, Anzueto A.Clinical Publishing, Oxford, United Kingdom2009
• Practical Cardiology 
  Chapter: Dyspnea. 
  Page 19 - 35Martinez FJ, Han MK, Aaronson KEditors: Baliga RR, Eagle KA.Lippincott, Williams & Wilkins, Philadelphia, PAEdition 2nd,2008
• Clinical Management of Chronic Obstructive Pulmonary Disease. 
  Chapter: Surgical therapy for COPD. 
  Page 435 - 474Martinez FJ, Chang AC, Chan KMEditors: Rennard SI, Rodriguez-Roisin R, Huchon G, Roche N.Informa Healthcare, New York, NY2008
• Pulmonary Rehabilitation. Guidelines to Success. 
  Chapter: Pulmonary rehabilitation and lung volume reduction surgery. 
  Page 385 - 392Han MK, Gay SE, Martinez FJEditors: Hodgkin JE, Celli BR, Connors GL.Mosby Elsevier, St. Louis, MO2008
• Chronic Obstructive Pulmonary Disease. 
  Chapter: Surgical therapy for COPD. 
  Page 636 - 656Martinez FJEditors: Stockley R, Rennard S, Rabe K, Celli B.Blackwell Publishing, Malden, MA2007
• Contemporary Diagnosis and Management of COPD. 
  Anzueto A, Martinez FJHandbooks in Health Care Company, Newton, PA2007
• Encyclopedia of Respiratory Medicine. 
  Chapter: Interstitial lung disease: Idiopathic pulmonary fibrosis. 
  Page 440 - 447Martinez FJ, Hogaboam CM, Choi ES, Toews GB, Flaherty KR, Thannickal VJEditors: Laurent GJ, Shapiro SD.Elsevier Limited, Oxford, United Kingdom2006
• Schaecter�s Mechanisms of Microbial Disease 
  Chapter: Respiratory system infections. 
  Page 603 - 614Han MK, Martinez FJEditors: Engelberg NC, DiRita V, Dermody TS.Lippincott, Williams & Wilkins, Philadelphia, PAEdition 4th,2006
• Sarcoidosis. 
  Chapter: Pulmonary function testing in sarcoidosis. 
  Page 440 - 447Subramanian I, Flaherty KR, Martinez FJEditors: Baughman RP.Taylor & Francis, New York, NY2005
• Pulmonary Rehabilitation: Efficacy and Scientific Basis. 
  Chapter: Pulmonary rehabilitation and lung transplantation. 
  Page 304 - 311Gay SE, Martinez FJEditors: Donner CF, Ambrosino N, Goldstein R.Edward Arnold Publishers Limited, London, United Kingdom2005
• Functional Lung Imaging. 
  Chapter: The role of computed tomography in emphysema and lung volume reduction surgery. 
  Page 431 - 451Flaherty KR, Martinez FJEditors: Lipson DA, Van Beek EJR.Taylor & Francis, Boca Raton, FL2005
• Idiopathic Pulmonary Fibrosis. 
  Chapter: Role of physiologic assessment in usual interstitial pneumonia. 
  Page 137 - 165Martinez FJ, Lynch III JPEditors: Lynch III JP.Marcel Dekker, New York, NY2004
• Idiopathic Pulmonary Fibrosis. 
  Chapter: Role of high-resolution thin section computed tomographic scanning. 
  Page 167 - 136Zisman DA, Flaherty KR, Kazerooni EA, Martinez FJ, Lynch III JPEditors: Lynch III JP.Marcel Dekker, New York, NY2004
• Lung Cancer: Principles and Practice 
  Chapter: The Medical Evaluation and Management of the Lung Cancer Patient Pre-Treatment. 
  Martinez FJ, Iannettoni M, Lin JEditors: Pass HI, Carbone DP, Johnson DH, Minna JD, Turrisi III AT.Lippincott, Williams & Wilkins, Philadelphia, PAEdition 3rd,2004
• Idiopathic Pulmonary Fibrosis. 
  Chapter: Nonspecific interstitial pneumonia. 
  Page 101 - 136Martinez FJ, Flaherty KR, Travis WD, Lynch III JPEditors: Lynch III JP.Marcel Dekker, New York, NY2004
• Management of Non-neoplastic Advanced Lung Disease. 
  Chapter: Role of physiologic assessment in advanced interstitial lung disease. 
  Page 179 - 247Weisman IM, Lynch III JP, Martinez FJEditors: Maurer J.Marcel Dekker, New York, NY2003
• Management of Non-neoplastic Advanced Lung Disease. 
  Chapter: Management of non-bronchiectatic chronic obstructive pulmonary disease. 
  Page 271 - 337Martinez FJ, Gay SE, Flaherty KREditors: Maurer J.Marcel Dekker, New York, NY2003
• Practical Cardiology. Common Treatment of Common Cardiovascular Disorders. 
  Chapter: Dyspnea. 
  Page 16 - 29Martinez FJ, Aaronson KDEditors: Eagle KA, Baliga RR.Lippincott, Williams & Wilkins, Philadelphia, PA2003
• Lung Volume Reduction Surgery for Emphysema. 
  Chapter: Outcomes for lung volume reduction surgery: Short and long-term results. 
  Page 311 - 354Martinez FJEditors: Fessler HE, Reilly JJ, Sugarbaker D.Marcel Dekker, New York, NY2003
• Educational Review Manual in Pulmonary Disease. 
  Chapter: Evaluation of dyspnea. 
  Page 1 - 20Martinez FJCastle Connolly Graduate Medical Publishing, Ltd., New York, NY2003
• Progress in Respiratory Research, Volume 32: Clinical Exercise Testing. 
  Chapter: Cardiopulmonary exercise testing in unexplained dyspnea. 
  Page 81 - 88Gay SE, Weisman I, Flaherty KR, Martinez FJEditors: Weisman I, Zeballos RJ.Karger, Basel, Switzerland2002
• Progress in Respiratory Research, Volume 32: Clinical Exercise Testing. 
  Chapter: The role of cardiopulmonary exercise testing for patients with suspected metabolic myopathies and other neuromuscular disorders. 
  Page 242 - 253Flaherty KR, Weisman I, Zeballos J, Martinez FJEditors: Weisman I, Zeballos RJ.Karger, Basel, Switzerland2002
• Join now to see all

Abstracts/Posters

• Baseline Characteristics of Patients Enrolled in a Prospective Study of Riociguat for Pulmonary Hypertension Associated with Idiopathic Interstitial Pneumonia (RISE-II...
  Nathan SD, Collard HR, Cottin V, Hoeper MM, Martinez FJ, Malcolm S, DiCasoli C, Yao M, Wells A, Am J Respir Crit Care Med, 1/1/2016
• The Clinical Utility of a Genomic Diagnostic Test in Differentiating Usual Interstitial Pneumonia from Other Interstitial Lung Disease Pathologies.
  Wu X, Belloli EA, Rosenbluth M, Choi Y, Danese S, Flaherty KR, Martinez FJ, Am J Respir Crit Care Med, 1/1/2016
• Clinical Significance of Symptoms in Smokers with Preserved Spirometry.
  Woodruff PG, Barr RG, Bleecker ER, Christenson SA, Couper DJ, Curtis JL, Gouskova N, Hansel NN, Hoffman EA, Kanner R, Kleerup E, Lazarus SC, Martinez FJ, Paine R, Renn..., Am J Respir Crit Care Med, 1/1/2016
• Association Between Blood Biomarkers, CT Phenotype and COPD Stage in SPIROMICS.
  Taylor J, Degtiar I, Murray S, Xin Wang, Martinez CH, Erb-Downward JR, Marchetti N, Criner GJ, O�Neal WK, Couper DJ, Bowler RP, Mary Beth Scholand, Pirozzi C, Cooper C..., Am J Respir Crit Care Med, 1/1/2016
• Common Airway Variants and Risk of Chronic Obstructive Pulmonary Disease. The Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS).
  Smith BM, Hoffman EA, Bleecker ER, Couper DJ, Han MLK, Hansel NN, Kanner R, Kleerup E, Martinez FJ, Rennard SI, Woodruff PG, Barr RG, Am J Respir Crit Care Med, 1/1/2016
• Active Smoking is Associated with Increased Eosinophils in Bronchoalveolar Lavage but Not in Sputum or Peripheral Blood: SPIROMICS Immunophenotyping Sub-Study.
  Sara X. Li, Andrew J. Hirzel, Freeman CM, Crudgington SW, Stolberg VR, Sonstein J, Alexis NE, Basta PV, Carretta EE, Christenson SA, Couper DJ, Doerschuk CM, Han MLK, ..., Am J Respir Crit Care Med, 1/1/2016
• The Effect of Inhaled Low Dose Carbon Monoxide on Cytokine/Chemokine Production in Idiopathic Pulmonary Fibrosis.
  Rooney KT, Goldberg HJ, Hunninghake GM, Nakahira K, Siempos II, Flaherty KR, Martinez FJ, Garcia JGN, Lederer DJ, Osorio JC, Raghu G, Villalba JA, Lasky J, Collard HR,..., Am J Respir Crit Care Med, 1/1/2016
• Simtuzumab in Idiopathic Pulmonary Fibrosis (IPF): Baseline Demographic and Lung Function Data from a Clinical Trial.
  Raghu G, Brown KK, Collard HR, Lederer DJ, Martinez FJ, Paul W. Noble, Woo Song, Wells AU, Timothy P. Whalen, Lisa Lambert, Jason W. Chien, Jenny J. Zhang, Thomas G. O..., Am J Respir Crit Care Med, 1/1/2016
• Rare SERPINA1 Variants in the Multi-Ethnic SPIROMICS Population.
  Ortega VE, Li X, O�Neal WK, Emily J. Pennington, Barr RG, Couper DJ, Han MLK, Kanner R, Kleerup E, Martinez FJ, Peters SP, Rennard SI, Woodruff PG, Hoffman EA, Myers D..., Am J Respir Crit Care Med, 1/1/2016
• The Proteome Signature of Disease Progression in Idiopathic Pulmonary Fibrosis.
  O'Dwyer DN, Ashley S, Xia M, Murray S, Grant E, White ES, Flaherty KR, Martinez FJ, Moore BB, Am J Respir Crit Care Med, 1/1/2016
• Biomarker Characterization of a Debilitated Phenotype in SPIROMICS.
  Barjaktaveric I, Martinez CH, Curtis JL, Bowler RP, O�Neal WK, Hoffman EA, Carretta EE, Miguel Quibrera, Barr RG, Bleecker E, Couper DJ, Criner GJ, Dransfield MT, Han ..., Am J Respir Crit Care Med, 1/1/2016
• Impact of Cardiovascular Co-Morbidities on FEV1 Change in Smokers: An Analysis of the COPDGene Cohort.
  Maselli DJ, Diaz AA, Victor Kim, Putcha N, Matthew J. Budoff, Edwin J. Van Beek, Foreman MG, Kinney GL, Hokanson J, Curtis JL, Martinez FJ, Tadashi A, Bowler RP, Regan..., Am J Respir Crit Care Med, 1/1/2016
• Growth Differentiation Factor-15 (GDF-15) Levels in Chronic Obstructive Pulmonary Disease Are Independently Associated with Subclinical Coronary Atherosclerosis: An An...
  Martinez CH, Freeman CM, Nelson JD, Matthew J. Budoff, Murray S, Xin Wang, Surya P. Bhatt, Bowler RP, Dransfield MT, Guo L, Hokanson J, Kinney GL, Martinez FJ, Regan E..., Am J Respir Crit Care Med, 1/1/2016
• Phenotypic/Genetic Characteristics of COPD, Asthma, and Asthma-COPD Overlap Syndrome (ACOS) in SPIROMICS and SARP.
  Li X, Ortega VE, Hansel Nadia, S, Moore WC, Huashi Li, Barr RG, Couper DJ, Hoffman EA, Han MLK, Kanner R, Kleerup E, Martinez FJ, Gregory A. Hawkins, Woodruff PG, Blee..., Am J Respir Crit Care Med, 1/1/2016
• Genome-Wide Association Identifies rs28929474 (Glu342Lys) in SERPINA1 Associated with Post-Bronchodilator FEV1/FVC and Percent Predicted FEV1 in SPIROMICS.
  Li X, Ortega VE, Ampleford EJ, Barr RG, Couper DJ, Han MLK, Hoffman EA, Kanner R, Kleerup E, Martinez FJ, Woodruff PG, Gregory A. Hawkins, Bleecker ER, Myers DA, Am J Respir Crit Care Med, 1/1/2016
• Multiscale Imaging-Based Clusters in the COPD Cohort Associates with Clinical Characteristics: The SubPopulations and InteRmediate Outcome Measures in COPD Study (SPIR...
  Haghighi B, Choi S, Hoffman EA, John Newell J, Barr RG, Han MLK, Cooper CB, O�Neal WK, Woodruff PG, Bleecker ER, Martinez FJ, Lin CL, Am J Respir Crit Care Med, 1/1/2016
• Analysis of Changes in the Lung Microbiome and Host Parameters in Current and Former Smokers with and Without COPD in the SPIROMICS Cohort.
  Erb-Downward JR, Han MLK, Freeman CM, Brown JP, Christenson s, Cooper CB, Barr RG, Hansel NN, Kanner R, Zeidler M, Wendy Moore, Bleecker E, Nicole Falkowski, Dustin Fa..., Am J Respir Crit Care Med, 1/1/2016
• Fissure Integrity and Rate of Emphysema Progression: SubPopulations and InteRmediate Outcome Measures In COPD Study (SPIROMICS).
  Dougherty TM, Newell JD, Yin Y, Schirm JA, Sieren JP, Barr RG, Bleecker E, Bowler RP, Comellas AP, Cooper CB, Criner GJ, Dransfield MT, Hansel NN, Han MLK, Kanner R, L..., Am J Respir Crit Care Med, 1/1/2016
• Reported Pneumonia Events in the SUMMIT Trial.
  Crim C, Anderson JA, Brook RD, Calverley PMA, Celli BR, Kilbride S, Martinez FJ, Newby DE, Yates J, Vestbo J, Am J Respir Crit Care Med, 1/1/2016
• Current Smoking Increases Macrophage Numbers and Immunoregulatory Receptor Expression in Bronchoalveolar Lavage but not Sputum in Chronic Obstructive Pulmonary Disease...
  Brown JP, Freeman CM, Sean W. Crudgington, Valerie R. Stolberg, Joanne Sonstein, Alexis NE, Basta PV, Carretta EE, Christenson s, Couper DJ, Doerschuk CM, Hansel NN, H..., Am J Respir Crit Care Med, 1/1/2016
• Join now to see all

Lectures

• COPD: Disease Pathogenesis & Management of Stable Patients 
  Open Medical Institute, Salzburg, Austria - 1/22/2018
• Evaluation of Common Pulmonary Symptoms 
  Open Medical Institute, Salzburg, Austria - 1/22/2018
• Management of COPD/New Therapies 
  Open Medical Institute, Salzburg, Austria - 1/22/2018
• IPF. Study design: between genetics and pragmatism 
  Taormina, Italy - 1/20/2018
• Disease Modification in COPD: Practical Considerations for Clinical Trial Design 
  San Diego, CA - 1/19/2018
• Highlights in COPD and Interstitial Lung Disease 
  San Diego, CA - 1/19/2018
• Precision Medicine and Pharmacogenomics for treatment of IPF: Ready or not for prime time 
  San Diego, CA - 1/19/2018
• Spanning the spectrum of COPD: Finding those that need therapy now and those that may need therapy in the future 
  Ottawa, Canada - 1/17/2018
• IPF: The role of modulating host immune response in personalizing therapy 
  Dartmouth-Hitchcock Medical Center - 1/12/2018
• Idiopathic Pulmonary Fibrosis (IPF): A paradigm for precision medicine in lung disease 
  Massachusetts General Hospital, Boston, MA - 1/10/2018
• Genetic loci associated with COPD 
  Florence, Italy - 1/3/2018
• Lung function decline in COPD and IPF 
  Florence, Italy - 1/3/2018
• Master Clinician: Diffuse Lung Diseases 
  1/31/2017
• Where has COMET brought us? 
  University of Alabama, Birmingham, AL - 1/29/2017
• COPD Management 
  Bon Secours Hospital, Grosse Pointe, MI, 2001; New York University, New York, NY, 2017 - 1/28/2017
• Bronchodilators focused on treatable traits in airways diseases 
  Rome, Italy - 1/20/2017
• IPF: Precision medicine and endpoints for assessing treatment response beyond forced vital capacity 
  Washington, DC - 1/20/2017
• PRO: Oxygen therapy benefits patients with mild to moderate hypoxemia at rest and those with desaturation on exertion only 
  Washington, DC - 1/20/2017
• Risks and benefits of anti-inflammatory drugs and antibiotics 
  1/18/2017
• What have we learned from major trials in COPD? 
  1/18/2017
• Interstitial Lung Disease, Clinical 
  New York, NY - 1/16/2017
• Late Breaking Science: Pulmonary 
  1/13/2017
• Asthma and COPD Overlap Syndrome: What is it and how should we be treating it? 
  Inova Fairfax Medical Campus, Falls Church, VA - 1/10/2017
• Challenges remaining for IPF treatment 
  Taipei, Taiwan - 1/10/2017
• Antifibrotic therapy in non-IPF lung diseases 
  Basel, Switzerland - 1/7/2017
• Join now to see all

Other

• Long-term management: How is my COPD patient doing? 
  Martinez FJ, Medscape CME Activity
  http://www.medscape.com/viewarticle/552418
  1/22/2008
• COPD : Which treatment is right for my patient? 
  Make BJ, Martinez FJ, Medscape CME Activity
  http://www.medscape.com/viewarticle/549962
  1/27/2007
• Overview of ketolides, a new class of agents in the treatment of community-acquired RTIs. In: A CME Certified Monograph on Treatment of Respiratory Tract Infections. 
  Ciervo CA, Jenkins SG, Martinez FJ, UMDNJ-Center for Continuing and Outreach Education
  1/1/2005
• Lung Volume Reduction Surgery Update and Recommendations. Pulmonary and Critical Care Update. 
  Martinez FJ, American College of Chest Physicians
  http://www.chestnet.org/education/online/pccu/vol20/index.php
  1/1/2005
• Treatment of COPD exacerbations. American College of Chest Physicians Tools for Education CD-ROM. COPD Exacerbations: An evidence-based approach. 
  Martinez FJ
  1/1/2004
• Diagnosis of Interstitial Lung Disease. Pulmonary and Critical Care Update. 
  Martinez FJ, Flaherty KR, American College of Chest Physicians
  http://www.chestnet.org/education/online/pccu/vol18/
  1/1/2004
• New approach means faster diagnosis of shortness of breath. 
  Martinez FJ, Bria II WF, Bach D, Orbis Medical News, Inc.
  1/1/1993
• An important advance in the diagnosis of lung cancer-bronchoscopic ultrasound. 
  Martinez FJ, Orens JB, Bude RO, Orbis Medical News, Inc.
  1/1/1993
• Management of cough. 
  Martinez FJ, Bria II WF, Medical News Network
  1/1/1993
• Join now to see all